A new article provides an overview of the global state of the field for using focused ultrasound to treat breast cancer.
The authors outlined ongoing research using several mechanisms of action and five devices and highlighted the technology’s ability to engage the immune system.
Focused ultrasound has the potential to become an alternative or complement to existing treatments in the management of breast cancer.
Professor Constantin Coussios is the Director of the Institute of Biomedical Engineering at the University of Oxford.
His team has overseen the clinical translation of several technologies into first-in-human trials, including kidney and liver ablation and drug delivery to treat solid tumors.
“There are mentors and there are sponsors – someone to share with you ideas about ways to carve out your path that you couldn’t even think of at your stage. Those kinds of influences are so important.”
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
By using FUSF’s AI agent, you acknowledge and agree that your use is governed by FUSF’s Terms of Use Agreement. If you do not agree to be bound by the Terms of Use Agreement, you may not access or use FUSF’s AI agent.
